Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.59 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SCN4A | P35499 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.44 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.44 |
| ▸ | DPP4 | P27487 | 2/20 | 0.44 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL123765 | 1.00 | GABBR2 (0.59) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL288753 | 1.00 | GABBR2 (0.59) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Hydrochloric Acid SCHEMBL3874351 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Hydrochloric Acid SCHEMBL4150999 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL9386161 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Hydrochloric Acid SCHEMBL2934796 | 0.98 | GABBR2 (0.57) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| Acetamide SCHEMBL27677566 | 0.92 | GABBR2 (0.52) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL7244087 | 0.90 | GABBR2 (0.55) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL5846637 | 0.89 | KMT2A (0.49) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 | |
| SCHEMBL5845485 | 0.89 | KMT2A (0.49) | GABBR2GABBR1KMT2ASMN1; SMN2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2002 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119913351-A | Method for extracting iron element from red mud | 中泥(山东)环保科技有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-109790114-B | Novel chiral ligand, metal chelate, various unnatural amino acids and synthesis method of maraviroc and key intermediate thereof | 中国科学院上海药物研究所 | 2025-03-07 | — | — | CN | claimed |
| CN-118955306-B | Improved process method of dapoxetine hydrochloride | 广州市桐晖药业有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118996022-A | Organic leather tanning agent with covalent tanning characteristics, and preparation method and application thereof | 四川德赛尔新材料科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118955306-A | Improved process method of dapoxetine hydrochloride | 广州市桐晖药业有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118496175-A | TRADD inhibitor derivative and preparation method and application thereof | 安徽医科大学 | 2024-08-16 | — | — | CN | claimed |
| CN-118459329-A | Functionalized metal carboxylate and nanocrystalline polymer composite material prepared by using same | 河北工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-113880721-B | Synthesis method of dapoxetine | 湖南九典制药股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117362189-A | N-methyl amino acid compound and preparation method thereof | 南开大学 | 2024-01-09 | — | — | CN | claimed |
| WO-2023214011-A1 | ENZYMATIC METHOD FOR PREPARING (R)-3-AMINO-4-ARYL-BUTANOIC ACID DERIVATIVES | ENZYMICALS AG (DE) | 2023-11-09 | — | — | WO | claimed |
| CN-1036832-C | Composition containing a penem or carbapenem artibiotic and the use of the same | SANKYO CO (JP) | 1997-12-31 | — | — | CN | claimed |
| WO-1997044333-A1 | 1,2,4-OXADIAZOLES AS ADHESION-RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 1997-11-27 | — | — | WO | claimed |
| US-5656448-A | Dipstick immunoassay device | PRINCETON BIOMEDITECH CORPORATION (US) | 1997-08-12 | — | — | US | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0233155-A1 | Aminoacyloxymethyl compounds | CIBA-GEIGY AG (CH) | 1987-08-19 | — | — | EP | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| CN-86107574-A | Compositions containing penem or carbapenem antibiotics and their use | — | 1987-05-20 | — | — | CN | claimed |
| US-4308269-A | ANTITUMOUR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-12-29 | — | — | US | claimed |
| EP-0021173-A1 | Maytansinoids, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-01-07 | — | — | EP | claimed |